LPL Financial’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $106K | Buy |
35,000
+12,000
| +52% | +$36.4K | ﹤0.01% | 5108 |
|
2025
Q1 | $98K | Sell |
23,000
-13,000
| -36% | -$55.4K | ﹤0.01% | 4919 |
|
2024
Q4 | $190K | Sell |
36,000
-10,000
| -22% | -$52.8K | ﹤0.01% | 4709 |
|
2024
Q3 | $84.2K | Buy |
46,000
+2,000
| +5% | +$3.66K | ﹤0.01% | 4822 |
|
2024
Q2 | $91.5K | Buy |
44,000
+16,000
| +57% | +$33.3K | ﹤0.01% | 4660 |
|
2024
Q1 | $112K | Buy |
28,000
+16,000
| +133% | +$64.2K | ﹤0.01% | 4582 |
|
2023
Q4 | $22.5K | Buy |
12,000
+2,000
| +20% | +$3.75K | ﹤0.01% | 4663 |
|
2023
Q3 | $16.7K | Hold |
10,000
| – | – | ﹤0.01% | 4562 |
|
2023
Q2 | $23.9K | Sell |
10,000
-25
| -0.2% | -$60 | ﹤0.01% | 4448 |
|
2023
Q1 | $31.4K | Buy |
+10,025
| New | +$31.4K | ﹤0.01% | 4340 |
|